Fiscal impact reports (FIRs) are prepared by the Legislative Finance Committee (LFC) for standing finance
committees of the NM Legislature. The LFC does not assume responsibility for the accuracy of these reports
if they are used for other purposes.
Current FIRs (in HTML & Adobe PDF formats) are a vailable on the NM Legislative Website (legis.state.nm.us).
Adobe PDF versions include all attachments, whereas HTML versions may not. Previously issued FIRs and
attachments may be obtained from the LFC in Suite 101 of the State Capitol Building North.
F I S C A L I M P A C T R E P O R T
SPONSOR HBIC
DATE TYPED 03/07/05 HB 199/HBICS
SHORT TITLE Amend Optometry Act
SB
ANALYST McSherry
APPROPRIATION
Appropriation Contained Estimated Additional Impact Recurring
or Non-Rec
Fund
Affected
FY05
FY06
FY05
FY06
Minimal Recurring Optometry
Board Fund
(Parenthesis ( ) Indicate Expenditure Decreases)
SOURCES OF INFORMATION
LFC Files
Regulations and Licensing Department (RLD)
Health Policy Commission (HPC)
Human Services Department (HSD)
SUMMARY
Synopsis of House Business and Industry Substitute Bill
House Business and Industry Committee Substitute for HB199 proposes to amend the Optometry
Act to increase the scope of optometry by removing restrictions on oral pharmaceuticals, ex-
pands the use of surgical procedures and injections for treatment of the human eye. The effective
date of the bill is July 1, 2005.
House Bill 199 amends the Optometry Act by adding language to increase the scope of optome-
try, and removing restrictions on oral pharmaceuticals such as the use of surgical procedures and
injections for treatment of the human eye.
Specifically, the bill proposes the replacement of specific language restricting surgery or injec-
tions for treatment with specific language describing the surgical and injection procedures which
would included in the practice of optometry. The proposed changes would allow laser posterior
capsulotomy (cataract implants); laser trabeculoplasty (drainage of fluids); laser iridotomy; laser
iridoplasty; photorefractive keratectomy; and phototherapeutic keratectomy; and minor surgical
procedures and injections for the correction, relief, treatment or referral of visual defects or ab-
normal conditions of the human eye and its adnexa, including removal of superficial lesions on
the eyelid and conjunctiva, subcutaneous and sub-conjunctival anesthetic injections and intrale-
sional steroid injections of chalazions and injection to treat anaphylactic reaction.” The substi-